Molbio Diagnostics IPO: GMP at 16%; should you apply as offer opens today?

Molbio Diagnostics IPO: Molbio is a molecular diagnostic company that develops, manufactures, and commercializes point-of-care (POC) molecular diagnostic platforms.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.